| scholarly article | Q13442814 |
| P2093 | author name string | Joosten LA | |
| van den Berg WB | |||
| van de Loo FA | |||
| Helsen M | |||
| P2860 | cites work | Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor | Q24294731 |
| Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis | Q24564656 | ||
| The role of cytokines and their inhibitors in arthritis | Q35233166 | ||
| Cytokines in autoimmunity | Q35605060 | ||
| Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death | Q36091620 | ||
| Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody | Q36360942 | ||
| Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats | Q36989932 | ||
| Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice | Q37147228 | ||
| Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis | Q37253521 | ||
| Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint | Q37408069 | ||
| Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation | Q41220989 | ||
| Cationic immune complex arthritis in mice--a new model. Synergistic effect of complement and interleukin-1. | Q41863475 | ||
| Antigen handling in antigen-induced arthritis in mice: an autoradiographic and immunofluorescence study using whole joint sections | Q42579715 | ||
| Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis | Q44064388 | ||
| Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor- | Q46027891 | ||
| Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage | Q59063497 | ||
| Immunity to cartilage proteoglycans in balb/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan | Q61658725 | ||
| Flare-up of experimental arthritis in mice with murine recombinant IL-1 | Q67742256 | ||
| Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor | Q67869949 | ||
| In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice | Q68095946 | ||
| T-cell vaccination | Q68105729 | ||
| Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis | Q68112952 | ||
| Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide | Q68134271 | ||
| Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta | Q68223818 | ||
| Experimental synovitis induced by collagen-specific T cell lines | Q69735058 | ||
| Interleukin-1 potentiates the development of collagen-induced arthritis in mice | Q69738800 | ||
| Impact of NSAIDS on murine antigen induced arthritis. I. Investigation of antiinflammatory and chondroprotective effects | Q69789483 | ||
| In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice | Q70146030 | ||
| IL-1 antagonism in inflammatory arthritis | Q72208829 | ||
| Influence of the severity and duration of murine antigen-induced arthritis on cartilage proteoglycan synthesis and chondrocyte death | Q93590965 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 237-243 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment | |
| P478 | volume | 95 |
| Q71576582 | 3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts |
| Q24812222 | Accelerated development of arthritis in mice lacking endothelial selectins |
| Q72106176 | Accelerated onset of collagen-induced arthritis by remote inflammation |
| Q77394194 | An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis |
| Q24801075 | Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice |
| Q24805245 | Anti-cytokine therapy in chronic destructive arthritis |
| Q40963908 | Anti-cytokine therapy in rheumatoid arthritis |
| Q57351157 | Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats |
| Q34071253 | Anti-interleukin 6 receptor antibody treatment in rheumatic disease |
| Q34071312 | Arguments for interleukin 1 as a target in chronic arthritis |
| Q41335748 | Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes |
| Q77872967 | Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression |
| Q71740178 | Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 |
| Q45985480 | Baicalein inhibits interleukin-1β-induced proliferation of human rheumatoid arthritis fibroblast-like synoviocytes. |
| Q27667652 | Bispecific digoxigenin-binding antibodies for targeted payload delivery |
| Q34071308 | Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha |
| Q41832023 | Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. |
| Q34447437 | Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritis |
| Q41639546 | Collagen-induced arthritis, an animal model of autoimmunity |
| Q36371110 | Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis |
| Q45258734 | Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis |
| Q28217681 | Cytokine traps: multi-component, high-affinity blockers of cytokine action |
| Q38943162 | Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses. |
| Q78124718 | Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice |
| Q36375776 | Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice |
| Q46931305 | Dietary trans-10,cis-12 CLA reduces murine collagen-induced arthritis in a dose-dependent manner |
| Q44060152 | Docosahexaenoic acid reduces inflammation and joint destruction in mice with collagen-induced arthritis |
| Q45861247 | Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA). |
| Q47733564 | Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice |
| Q85602224 | Evaluation of complete Freund's adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology |
| Q37316594 | Evidence that cytokines play a role in rheumatoid arthritis |
| Q70911205 | High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant |
| Q33578584 | IL-1 has no direct role in the IGF-1 non-responsive state during experimentally induced arthritis in mouse knee joints |
| Q37696955 | IL-1 pathways in inflammation and human diseases |
| Q37202023 | IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion |
| Q92715269 | IL1R1 polymorphisms are associated with ankylosing spondylitis in the Han Chinese population: a case-control study |
| Q40430530 | IL37 dampens the IL1β-induced catabolic status of human OA chondrocytes |
| Q44198853 | Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway |
| Q74068769 | Interactions between H-2 and background genes modulate collagen induced arthritis in high (HI) and low (LI) antibody producer Biozzi mice |
| Q35630027 | Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases |
| Q39246542 | Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. |
| Q35041474 | Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis |
| Q44060534 | Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. |
| Q24316553 | JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression |
| Q77627736 | Joint inflammation and cartilage destruction may occur uncoupled |
| Q34775626 | Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis |
| Q77419153 | Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product |
| Q71803587 | Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo |
| Q36366486 | Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. |
| Q45885757 | Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. |
| Q43070178 | Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules |
| Q94031953 | Monitor: molecules and profiles |
| Q40433213 | Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease |
| Q41837758 | Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage |
| Q40576901 | P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor. |
| Q92055384 | Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice |
| Q34276030 | Potential biologic agents for treating rheumatoid arthritis |
| Q36622363 | Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. |
| Q30863549 | Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases |
| Q43524051 | Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis |
| Q24792053 | Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis |
| Q40684474 | Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224‐015, an inhibitor of the interleukin‐1β converting enzyme |
| Q42163509 | Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration |
| Q35225283 | Regulation of early complement components C3 and C4 in the synovium |
| Q36751123 | Repeated, but not acute, stress suppresses inflammatory plasma extravasation |
| Q72065803 | Role of cytokines in experimental arthritis |
| Q35617341 | Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal models |
| Q35797922 | Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. |
| Q39570137 | Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae. |
| Q33782333 | Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction |
| Q34830578 | Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models |
| Q34420356 | Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion |
| Q50890094 | Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. |
| Q42439754 | Skewed balance in basal expression and regulation of activating v inhibitory Fcgamma receptors in macrophages of collagen induced arthritis sensitive mice |
| Q24799986 | Staphylococcal peptidoglycans induce arthritis |
| Q41510713 | Structure and function of interleukin-1 beta converting enzyme. |
| Q45864343 | Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy |
| Q24792883 | Synovial cytokine mRNA expression during arthritis triggered by CpG motifs of bacterial DNA |
| Q43723295 | Synthesis and bioactivities of novel 5,6-bis(4-methoxyphenyl)-2H-pyridazin-3-one derivatives: inhibitors of interleukin-1 beta (IL-1beta) production |
| Q43723293 | Synthesis and bioactivities of novel pyridazine derivatives: inhibitors of interleukin-1 beta (IL-1beta) production |
| Q58998545 | T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4ig but is successfully treated by interleukin-17 neutralization |
| Q33566525 | The prospect for cytokine based therapeutic strategies in rheumatoid arthritis |
| Q41228313 | The role of macrophages in chronic arthritis |
| Q71889641 | The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice |
| Q36319606 | The use of anakinra in juvenile arthritis |
| Q37736260 | Therapeutic antibodies for autoimmunity and inflammation |
| Q77627754 | Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody |
| Q34217504 | VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis |
| Q79264738 | Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis |
| Q37008483 | Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells |
Search more.